miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML)
about
The Role of MicroRNAs in Myeloproliferative NeoplasiaMicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemiaRal GTPases in tumorigenesis: emerging from the shadowsSemi-supervised learning for potential human microRNA-disease associations inferenceRalA downstream regulated genesThe role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data.MiR-181a contributes to bufalin-induced apoptosis in PC-3 prostate cancer cells.Differential expression of microRNAs in dorsal root ganglia after sciatic nerve injury.MiR-181a regulates inflammation responses in monocytes and macrophagesPrognostic role of microRNA-181a/b in hematological malignancies: a meta-analysisHow microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation.Post-stroke treatment with miR-181 antagomir reduces injury and improves long-term behavioral recovery in mice after focal cerebral ischemia.Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.Differential expression of microRNAs in bovine papillomavirus type 1 transformed equine cells.Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.MicroRNA-130a regulates cell malignancy by targeting RECK in chronic myeloid leukemia.RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.MicroRNAs as Haematopoiesis Regulators.Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a.MicroRNAs in myeloid malignancies.miR-181a-2 downregulates the E3 ubiquitin ligase CUL4A transcript and promotes cell proliferation.MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells.miRNAs in chronic myeloid leukemia: small molecules, essential function.Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).Novel role of miR-181a in cartilage metabolism.miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia.miRNA-mediated deregulation in leukemia.Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia.Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.
P2860
Q26739435-0F758CC1-48AA-4689-BDFE-167950049647Q26766288-F8FCB04A-CBAB-4BBD-A6FA-0BEBD1679AB2Q28294053-E7859296-DA64-4AFE-B2B0-2E599555B1EBQ28656510-186DF9F9-2EF4-44CB-8C6D-2EC13524141FQ30230784-5ABD1F3D-75BE-42E7-BDD4-519BF77B1272Q30883662-C03E4435-43B7-46D2-AB08-F9B12D8D7C4CQ31144343-7D0884E2-6684-4CB8-990B-44B0C9A0A52BQ34096286-BB62F1DB-2B63-4002-A4A2-02A281B43DE4Q34629860-4FF473B4-B934-4B5F-BE10-697A14EAB849Q34637868-2EFBB854-82C4-4763-BA9D-13E304E5CE9BQ34979339-AB688A6D-0217-48E1-84DE-7E1B82DAF91CQ35072479-8F70B114-610D-4392-8943-86461FD7834BQ35125641-261F26B0-32D9-486D-A9DB-15CE2E3B6D0EQ35811902-4E34D55E-0671-4AA0-B0EB-925AC1CC7F90Q35978278-71D8F261-D50A-4263-98AB-C1332474CF14Q36099935-C2BB1EB6-8B0F-4063-AB4A-B6ACDE428F1FQ36841290-32FA288F-F3AF-4424-8B4E-9FA5DF019381Q37190370-26B59A05-FF76-4B3C-811E-0E6413552243Q37448597-F824F69A-2DDC-4599-8E6F-07B840C6FDA7Q37634250-E92968BC-1635-4ED2-A1BD-DE7FD6DB4B79Q38107272-E4CC201C-B8B6-4549-945C-16A00BAC220AQ38668774-70428EF0-05BD-4DAD-BD69-910C550F4D91Q38858703-44C085B3-6344-4AA3-8C49-B93736267528Q38979577-E33D3A89-285C-4FF1-92D8-2651C11E6801Q39032370-17E1543A-986A-4B0F-8E68-1057B793349AQ39137771-8F991727-5902-4059-A4C4-69A3ABD8CEE6Q39171932-0E667DAD-78EA-4DC6-A0CC-9E9B4B6BF8B0Q41818086-7E4A9178-E6FF-43EE-B944-875ADE1AE11BQ41851975-9BCE24E8-836C-4A8D-AD00-111A6EAD27C0Q42253878-9478DF0F-9A5C-4B5E-89B3-0596B91DAB85Q42996940-74FC357C-5BBB-4E54-9CE0-C108643801E1Q47216949-48C867A1-0F00-4118-B20C-CDE50E62A7BDQ50240916-12DF2FD9-BAFA-4AE9-96F0-6CB5B538E1D7
P2860
miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
miR-181a post-transcriptionall ...... nic myelogenous leukemia (CML)
@ast
miR-181a post-transcriptionall ...... nic myelogenous leukemia (CML)
@en
type
label
miR-181a post-transcriptionall ...... nic myelogenous leukemia (CML)
@ast
miR-181a post-transcriptionall ...... nic myelogenous leukemia (CML)
@en
prefLabel
miR-181a post-transcriptionall ...... nic myelogenous leukemia (CML)
@ast
miR-181a post-transcriptionall ...... nic myelogenous leukemia (CML)
@en
P2093
P2860
P1433
P1476
miR-181a post-transcriptionall ...... nic myelogenous leukemia (CML)
@en
P2093
Xiaochuang Luo
Xuejiao Zhu
P2860
P304
P356
10.1371/JOURNAL.PONE.0032834
P407
P577
2012-03-19T00:00:00Z